Human papillomavirus (HPV)-associated cervical cancers are considered to be immunogenic tumors with increased neoantigen formation, high somatic mutation rate, and enhanced programmed death-ligand 1 (PD-L1) expression [29, 30]. Here, CD274 is linked to cervical carcinoma.